4893 items matching your search terms.

A multicenter, randomized phase III maintenance study of thalidomide (arm A) vs. observation (arm B) in patients with malignant pleural mesothelioma after induction chemotherapy

Buikhuisen, WA Vincent, A Van Klaveren, RJ Schram, F Pavlakis, N Nowak, A Custers, F Schouwink, H Groen, HJM Strankinga, WFM Burgers, JA Baas, P

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: A randomised controlled trial

Bulbulia, R. Bowman, L. Wallendszus, K. Parish, S. Armitage, J. Peto, R. Collins, R. Collins, R. Meade, T. Sleight, P. Armitage, J. Parish, S. Peto, R. Youngman, L. Buxton, M. De Bono, D. George, C. Fuller, J. Keech, A. Mansfield, A. Pentecost, B. Simpson, D. Warlow, C. McNamara, J. O'Toole, L. Doll, R. Wilhelmsen, L. Fox, K. M. Hill, C. Sandercock, P.
THE LANCET, 2011     DOI:10.1016/S0140-6736(11)61125-2

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial

Bulbulia, R. Bowman, L. Wallendszus, K. Parish, S. Armitage, J. Peto, R. Collins, R. Meade, T. Sleight, P. Youngman, L. Buxton, M. De Bono, D. George, C. Fuller, J. Keech, A. Mansfield, A. Pentecost, B. Simpson, D. Warlow, C. McNamara, J. O'Toole, L. Doll, R. Wilhelmsen, L. Fox, K. M. Hill, C. Sandercock, P.
LANCET, 2011     DOI:10.1016/S0140-6736(11)61125-2

Emergency department workforce models: what the literature can tell us

Callander, EJ Schofield, DJ
EMERGENCY MEDICINE AUSTRALASIA, 2011     DOI:10.1111/j.1742-6723.2010.01378.x

Multi-dimensional poverty in Australia and the barriers ill health imposes on the employment of the disadvantaged

Callander, E Schofield, D Shrestha, R

Capacity for freedom — a new way of looking at rural-urban differences

Callander, E Schofield, D Shrestha, R

Biomarkers in oesophagogastric cancers

Cameron, A Barbour, A Wayte, N Akhurst, T

Overview of controversies in oesophagogastric cancer

Cameron, A Sjoquist, KM Zalcberg, JR

Heterogeneity of FDG-PET response to GSK2118436, an inhibitor of oncogenic mutant BRAF-kinase in BRAF-mutant metastatic melanoma

Carlino, MS Saunders, CA Gebski, V Menzies, AM Ma, B Lebowitz, PF Kefford, R Long, GV

Toxicity-adjusted dose administration of chemotherapy: effect of baseline and nadir neutrophil count in patients with breast, ovarian, and lung cancer?

Carus, A Donskov, F Gebski, V Kefford, R Wilcken, N Hui, R Harnett, PR Ladekarl, M von der Maase, H Gurney, H

Serum total bilirubin levels predict amputation events in type 2 diabetic mellitus

Chan, KH Stocker, R Sullivan, D Rajamani, K Ng, M O'Connell, R Keech, A

Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis

Changsirivathanathamrong, D Wang, Y Rajbhandari, D Maghzal, GJ Mak, WM Woolfe, C Duflou, J Gebski, V Dos Remedios, CG Celermajer, DS Stocker, R.
CRITICAL CARE MEDICINE, 2011     DOI:10.1097/CCM.0b013e31822827f2

Patient-reported outcomes of prostate high-dose-rate brachytherapy boost comparing an outpatient and inpatient protocol: A two-center chronologic cohort study

Chen, JY Hruby, G Stockler, MR Patanjali, N Bucci, J Perez, G Loadsman, JA Sheehan, E

Mechanisms for the therapeutic effect of fenofibrate on diabetic retinopathy in type 1 diabetes models

Chen, Y Hu, Y Mott, R Mitchell, S Jenkins, AJ Keech, AC Lyons, TJ Ma, JX

Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis [Correction: European Journal of Cancer 2012; 48(3): 407]

Clarke, SJ Yip, S Brown, C van Hazel, GA Ransom, DT Goldstein, D Jeffrey, GM Tebbut, NC Buck, M Lowenthal, RM Boland, A Gebski, V Zalcberg, J Simes, RJ on behalf of the Australasian Gastro-Intestinal Trials Group,
EUROPEAN JOURNAL OF CANCER, 2011     DOI:10.1016/j.ejca.2011.12.001